Literature DB >> 19563531

A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena.

S Schuhmacher1, E Schulz, M Oelze, A König, C Roegler, K Lange, L Sydow, T Kawamoto, P Wenzel, T Münzel, J Lehmann, A Daiber.   

Abstract

BACKGROUND AND
PURPOSE: The chronic use of organic nitrates is limited by serious side effects including oxidative stress, nitrate tolerance and/or endothelial dysfunction. The side effects and potency of nitroglycerine depend on mitochondrial aldehyde dehydrogenase (ALDH-2). We sought to determine whether this concept can be extended to a new class of organic nitrates with amino moieties (aminoalkyl nitrates). EXPERIMENTAL APPROACH: Vasodilator potency of the organic nitrates, in vitro tolerance and in vivo tolerance (after continuous infusion for 3 days) were assessed in wild-type and ALDH-2 knockout mice by isometric tension studies. Mitochondrial oxidative stress was analysed by L-012-dependent chemiluminescence and protein tyrosine nitration. KEY
RESULTS: Aminoethyl nitrate (AEN) showed an almost similar potency to glyceryl trinitrate (GTN), even though it is only a mononitrate. AEN-dependent vasodilatation was mediated by cGMP and nitric oxide. In contrast to triethanolamine trinitrate (TEAN) and GTN, AEN bioactivation did not depend on ALDH-2 and caused no in vitro tolerance. In vivo treatment with TEAN and GTN, but not with AEN, induced cross-tolerance to acetylcholine (ACh)-dependent and GTN-dependent relaxation. Although all nitrates tested induced tolerance to themselves, only TEAN and GTN significantly increased mitochondrial oxidative stress in vitro and in vivo. CONCLUSIONS AND IMPLICATIONS: The present results demonstrate that not all high potency nitrates are bioactivated by ALDH-2 and that high potency of a given nitrate is not necessarily associated with induction of oxidative stress or nitrate tolerance. Obviously, there are distinct pathways for bioactivation of organic nitrates, which for AEN may involve xanthine oxidoreductase rather than P450 enzymes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563531      PMCID: PMC2757691          DOI: 10.1111/j.1476-5381.2009.00303.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.

Authors:  R J Gryglewski; A Zembowicz; D Salvemini; G W Taylor; J R Vane
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations.

Authors:  W P Arnold; C K Mittal; S Katsuki; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

3.  Sulfhydryl reactivity of organic nitrates: biochemical basis for inhibition of glyceraldehyde-P dehydrogenase and monoamine oxidase.

Authors:  B Jakschik; P Needleman
Journal:  Biochem Biophys Res Commun       Date:  1973-07-17       Impact factor: 3.575

4.  The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

5.  Identification of the enzymatic mechanism of nitroglycerin bioactivation.

Authors:  Zhiqiang Chen; Jian Zhang; Jonathan S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

6.  A new pitfall in detecting biological end products of nitric oxide-nitration, nitros(yl)ation and nitrite/nitrate artefacts during freezing.

Authors:  Andreas Daiber; Markus Bachschmid; Cengiz Kavaklí; Daniel Frein; Maria Wendt; Volker Ullrich; Thomas Munzel
Journal:  Nitric Oxide       Date:  2003-08       Impact factor: 4.427

7.  Synthesis and collateral dilator activity of nitroxyalkylamides having direct or latent sulfhydryl moieties.

Authors:  Sadao Ishihara; Fujio Saito; Yasuo Ohhata; Marie Kanai; Hiroshi Mizuno; Michio Fujisawa; Ryosuke Yorikane; Hiroyuki Koike
Journal:  Bioorg Med Chem Lett       Date:  2003-05-05       Impact factor: 2.823

8.  Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance.

Authors:  Karsten Sydow; Andreas Daiber; Matthias Oelze; Zhiqiang Chen; Michael August; Maria Wendt; Volker Ullrich; Alexander Mülsch; Eberhard Schulz; John F Keaney; Jonathan S Stamler; Thomas Münzel
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

9.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

10.  Pharmacokinetic profile of nicorandil in humans: an overview.

Authors:  A Frydman
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

View more
  14 in total

1.  2-Aminoethylnitrate: Earlier investigation as a drug was missed by recent authors due to changes in nomenclature.

Authors:  John Christie McGrath
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

2.  Response to a letter to the editor by Satvika Uppu.

Authors:  Andreas Daiber
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

3.  2-Aminoethylnitrate: pharmacological uses rediscovered and claimed as original.

Authors:  Satvika Uppu
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

4.  Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models.

Authors:  Swenja Kröller-Schön; Sebastian Steven; Sabine Kossmann; Alexander Scholz; Steffen Daub; Matthias Oelze; Ning Xia; Michael Hausding; Yuliya Mikhed; Elena Zinssius; Michael Mader; Paul Stamm; Nicolai Treiber; Karin Scharffetter-Kochanek; Huige Li; Eberhard Schulz; Philip Wenzel; Thomas Münzel; Andreas Daiber
Journal:  Antioxid Redox Signal       Date:  2013-08-17       Impact factor: 8.401

5.  Nitric oxide generation by the organic nitrate NDBP attenuates oxidative stress and angiotensin II-mediated hypertension.

Authors:  Suênia K P Porpino; Christa Zollbrecht; Maria Peleli; Marcelo F Montenegro; Maria C R Brandão; Petrônio F Athayde-Filho; Maria S França-Silva; Erik Larsson; Jon O Lundberg; Eddie Weitzberg; Erik G Persson; Valdir A Braga; Mattias Carlström
Journal:  Br J Pharmacol       Date:  2016-06-12       Impact factor: 8.739

Review 6.  Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications.

Authors:  Byoung-Joon Song; Mohamed A Abdelmegeed; Seong-Ho Yoo; Bong-Jo Kim; Sangmee A Jo; Inho Jo; Kwan-Hoon Moon
Journal:  J Proteomics       Date:  2011-05-15       Impact factor: 4.044

Review 7.  Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.

Authors:  Felix Fleissner; Thomas Thum
Journal:  Antioxid Redox Signal       Date:  2010-12-13       Impact factor: 8.401

8.  Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats.

Authors:  Hanke Mollnau; Matthias Oelze; Elena Zinßius; Michael Hausding; Zhixiong Wu; Maike Knorr; Jasmin Ghaemi Kerahrodi; Swenja Kröller-Schön; Thomas Jansen; Christine Teutsch; Carolyn Foster; Huige Li; Philip Wenzel; Eberhard Schulz; Thomas Münzel; Andreas Daiber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-02-27       Impact factor: 3.000

9.  Aminoethyl nitrate--the novel super nitrate?

Authors:  Johann Bauersachs
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

10.  Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy.

Authors:  Swenja Schuhmacher; Matthias Oelze; Franziska Bollmann; Hartmut Kleinert; Christian Otto; Tjebo Heeren; Sebastian Steven; Michael Hausding; Maike Knorr; Andrea Pautz; Kurt Reifenberg; Eberhard Schulz; Tommaso Gori; Philip Wenzel; Thomas Münzel; Andreas Daiber
Journal:  Diabetes       Date:  2011-08-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.